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Abstract
Background: The fractional concentration of nitric oxide in exhaled air (FENO) is used as a biomarker of
eosinophilic airway inflammation. FENO is increased in patients with asthma. The relationship between subjective
asthma symptoms and airway inflammation is an important issue. We expected that the subjective asthma
symptoms in women might be different from those in men. Therefore, we investigated the gender differences of
asthma symptoms and FENO in a survey of asthma prevalence in university students.
Methods: The information about asthma symptoms was obtained from answers to the European Community
Respiratory Health Survey (ECRHS) questionnaire, and FENO was measured by an offline method in 640 students
who were informed of this study and consented to participate.
Results: The prevalence of asthma symptoms on the basis of data obtained from 584 students (266 men and 318
women), ranging in age from 18 to 24 years, was analyzed. Wheeze, chest tightness, an attack of shortness of breath, or
an attack of cough within the last year was observed in 13.2% of 584 students. When 38.0 ppb was used as the cut-off
value of FENO to make the diagnosis of asthma, the sensitivity was 86.8% and the specificity was 74.0%. FENO was ≥ 38.0
ppb in 32.7% of students. FENO was higher in men than in women. The prevalence of asthma symptoms estimated by
considering FENO was 7.2%; the prevalence was greater in men (9.4%) than women (5.3%). A FENO ≥ 38.0 ppb was
common in students who reported wheeze, but not in students, especially women, who reported cough attacks.
Conclusions: The prevalence of asthma symptoms in university students age 18 to 24 years in Japan was
estimated to be 7.2% on the basis of FENO levels as well as subjective symptoms. Gender differences were
observed in both FENO levels and asthma symptoms reflecting the presence of eosinophilic airway inflammation.
Trial registration number: UMIN000003244
Background
Bronchial asthma is a chronic inflammatory disease char-
acterized by reversible airway limitation and airway hyper-
reactivity. Clinically, patients with asthma have repeated
symptoms, such as wheeze, shortness of breath, or cough,
especially at night or early morning. When we make a
diagnosis of asthma, it is helpful to expect that the patients
have eosinophilic airway inflammation although asthma is
not always associated with eosinophilic inflammation. In
recent years, the fractional concentration of nitric oxide in
exhaled air (the fraction of exhaled nitric oxide, FENO) has
been used as a biomarker of eosinophilic inflammation in
the airway [1-3]. In fact, FENO is increased in asthmatic
patients compared to healthy subjects [4]. Measurements
of FENO are useful for making the diagnosis of asthma,
and its sensitivity and specificity as a marker for the diag-
nosis are relatively high [5-8]. There are two procedures
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any medium, provided the original work is properly cited.for FENO measurements: online and offline. Exhaled gas is
collected in a reservoir and subsequently analyzed for
nitric oxide (NO) concentrations in offline measurements
[9]. Particularly in epidemiologic studies, offline measure-
ment might be superior to online measurement because it
is economical and makes it easy to measure a number of
samples in a short time [10,11].
Worldwide epidemiological surveys on adult asthma
have been mainly performed using the European Commu-
nity Respiratory Health Survey (ECRHS) questionnaire
[12-17]. Asthma symptoms including wheezing, a noctur-
nal feeling of tightness in the chest, a nocturnal attack of
shortness of breath, or a nocturnal attack of cough in the
ECRHS questionnaire are consistent with asthma, but cer-
tainly not specific for asthma. Moreover, we cannot guess
the degree of eosinophilic airway inflammation in each
subject based on the information obtained from a ques-
tionnaire. Therefore, we think that the combination of
FENO measurements and the questionnaire about asthma
symptoms might make it possible to develop a more
objective estimate in epidemiological studies of asthma
prevalence.
In this study, an analysis of the prevalence of asthma
symptoms in university students was attempted using
both the ECRHS questionnaire and FENO measured by
an offline method. Additionally, we tried to investigate
the gender differences in FENO levels and asthmatic
symptoms.
Methods
1. Subjects
This study was approved by the Institutional Review Board
of Gunma University Hospital, on January 27, 2010 and
registered with UMIN-CTR on February 13, 2010 (ID
number: UMIN000003244). Gunma University students
who participated in the study were asked to fill out an
ECRHS questionnaire (Japanese version) [18], and breath
samples were obtained. The study was performed from
April 1 to 9, 2010 when physical examinations for students
were done. The flowchart of this clinical study is shown in
Figure 1. We put up a notice that asked for participation
in our clinical study. Of the 3247 students who underwent
physical examinations, 643 students intended to take part
in this study and visited our room. These 643 students
were informed of the study in detail. The 640 students
consented to participate in the study and signed the con-
sent form. The receiver operating characteristic (ROC)
curve was produced using FENO data obtained from 504
samples out of 640 samples (Additional file 1). Samples
obtained from 38 students who had suffered from asthma
and had wheezing for the last year were used as samples
from an asthma group, and samples obtained from 466
students who had not suffered from asthma, did not have
any asthmatic symptoms, and had not experienced chronic
bronchitis-like symptoms were used as samples from a
non-asthma group. When 38.0 ppb was used as the cut-off
value to classify the subjects in this study, the sensitivity
was 86.8% and the specificity was 74.0%. To investigate
the prevalence of asthma symptoms in the specified gen-
eration, we used the data obtained from 584 Gunma Uni-
v e r s i t ys t u d e n t s( 2 6 6m a l ea n d3 1 8f e m a l es t u d e n t s ;a g e
range, 18 to 24 years; mean ± SD age, 19.6 ± 1.6 years)
and did not use the data from 56 students who were ≥ 25
years old in this investigation. The prevalence of asthma
symptoms was analyzed based on the previous 1-year
period.
2. Methods
The original 9 main questions containing sub-questions
translated into Japanese in the Japanese version of the
ECRHS a 1-page questionnaire were used in this study
[18,19]. Breath samples were obtained using an offline kit
produced by the Center for Environmental Information
Science (Tokyo, Japan) to measure FENO under the same
conditions as with online measurement [10,11]. In this
device, the expiratory flow rate is adjusted to 50 mL/s
when subjects exhale at 1.5 kPa oral pressure after inhaling
deeply. The adjustment was performed with a variable flux
pump (SIBATA, Soka, Japan). A disposable paper mouth-
piece and a viral and bacterial filter were connected to a
plastic mouthpiece adaptor with a pressure gauge, fol-
lowed by a plastic T-tube with a resistance valve and a bag
reservoir for collecting exhaled gas. A 1.5-L Mylar bag
(Sievers, Boulder, CO) was used for the reservoir bag. Dur-
ing expiration, subjects were asked to maintain a constant
mouth pressure (1.5 kPa) by looking at a pressure gauge.
Air exhaled in the first 5 seconds (250 mL) was discarded,
and the air exhaled between 5 to 10 seconds (250 mL) was
collected in the Mylar bag. Samples obtained in bags were
stored at 4°C to overcome error induced by sample storage
and FENO was measured within 8 hours using a chemilu-
minescence analyzer (NOA 280, Sievers).
3. Statistical analysis
Statistical analysis was performed using SPSS software
(SPSS Japan Inc., Tokyo, Japan). Differences in percentages
between two groups were analyzed using the chi-square
test, and differences in means between two groups were
analyzed using Student’s t-test.
Results
1. Gender differences in FENO and symptoms, especially
wheeze and nocturnal cough attacks
The students ranged in age from 18 to 24. The mean ±
SD FENO in 584 students was 36.7 ± 29.6 ppb, and was ≥
38.0 ppb in 191 (32.7%) of 584 students. Among the 266
male students, the mean FENO was 43.6 ± 34.0 ppb, and
was ≥ 38.0 ppb in 111 (41.7%) of 266 students. Among
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Page 2 of 8the 318 female students, the mean FENO was 31.0 ± 24.0
ppb, and was ≥ 38.0 ppb in 80 (25.2%) of 318 students.
FENO levels and the percentage of students whose FENO
was ≥ 38.0 ppb were significantly higher in men than in
women (p < 0.01, Figure 2).
FENO was ≥ 38.0 ppb in 38 (24 men and 14 women) of
the 50 students (27 men and 23 women) who had experi-
enced wheezing. It was ≥ 3 8 . 0p p bi n7( 3m e na n d4
women) of 24 students (5 men and 19 women) who had
a nocturnal attack of cough. The percentages of subjects
whose FENO was ≥ 38.0 ppb were 76.0% of the subjects
who had wheezing and 29.2% of those with a nocturnal
attack of cough. The percentage of students whose FENO
was ≥ 38.0 ppb was smaller in those who had nocturnal
attacks of cough than in those who had experienced
wheezing (Figure 3A). The percentage of students whose
FENO was ≥ 38.0 ppb in those who had experienced
wheezing was 88.9% in men and 60.9% in women; the dif-
ference was significant (p < 0.05) (Figure 3B). Although a
nocturnal attack of cough was relatively frequent in
women, only 4 (21.1%) of 19 female students who had
nocturnal attacks of cough had a FENO ≥ 38.0 ppb (Fig-
ure 3C).
2. Asthmatic symptoms in University students based on
the ECRHS questionnaire
Of the 584 students, 77 (13.2%) answered that they had
any asthmatic symptoms, including wheezing, a noctur-
nal feeling of tightness in the chest, a nocturnal attack of
shortness of breath, or a nocturnal attack of cough in the
last year (Figure 4A). Thus, the maximum prevalence of
asthma symptoms in Gunma University students was
13.2%. Thirty-three (12.4%) of 266 male students and 44
(13.8%) of 318 female students had asthmatic symptoms.
The percentage of students who had asthmatic symptoms
was not significantly different between men and women.
Of the 584 students, 50 (8.6 % )r e p o r t e dw h e e z i n g ,1 1
(1.9%) had a nocturnal feeling of tightness in the chest,
Put a notice that asked for participation in this clinical study to  
3247 students who underwent physical examinations
643 students
Intended to participate 
and  visited our room
2604 students
Did not visit our room
3 students
The consent form
was incomplete
640 students
Understood this clinical study
and signed the consent form
584 students  
Ranged in age 
from 18 to 24
38 student
Expected to 
have asthma
466 students
Expected not to 
have asthma
136 students
Others
Prevalence of asthma 
symptoms were analyzed
The ROC curve 
was constructed  
56 students
Others
Figure 1 The flowchart of this clinical study. We explained this clinical study in detail using brochure for 643 students who intended to take
part in our clinical study and visited the room. We got the consent forms adequately signed by 640 students. In order to investigate the
prevalence of asthma symptoms, we analyzed the information obtained from the ECRHS questionnaire andFENO data in 584 students whose
ages were from 18 to 24.
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Page 3 of 86 (1.0%) had a nocturnal attack of shortness of breath,
and 24 (4.1%) had a nocturnal attack of cough within the
last year. Overall, 10.2% (27 of 266) of men and 7.2% (23
of 318) of women had wheezing. On the other hand, sig-
nificantly more women (6.0%, 19 of 318) had a nocturnal
attack of cough than men (1.9%, 5 of 266; p < 0.05).
3. The prevalence of asthma symptoms based on the
ECRHS questionnaire and FENO measurement
FENO was over 38.0 ppb in 42 (25 men and 17 women)
of the 77 students who had any asthmatic symptoms.
Thus, the prevalence of asthma symptoms over 1 year
in Gunma University students was 7.2% of 584 students,
based on our definition of a predictive FENO and the
information about symptoms obtained from the ECRHS
questionnaire (Figure 4B). As a result of this analysis,
the prevalence of asthma symptoms was greater in men
(9.4%) than in women (5.3%).
4. Past history of asthma and current subjective symptoms
A total of 103 students (58 men and 45 women; 17.6% of
584 students) answered that they had suffered from
asthma, including 21.8% of 266 male students and 14.2%
of 318 female students; the difference between men and
women was significant (p < 0.05) (Figure 5A). Thirty six
(35.0%) of 103 students who suffered from asthma still
had asthmatic symptoms (Figure 5B). Overall, 19 (32.8%)
of 58 male students and 17 (37.8%) of 45 female students
with a past history of asthma still felt any asthmatic
symptoms. Of the 103 students who had suffered from
asthma, 16 were being treated at the time of the survey,
of whom only 3 had been treated well and had no asth-
matic symptoms within the last year. Only 36.1% of the
36 students with current asthmatic symptoms and a past
history of asthma were being treated medically at the
time of the survey, and the other 63.9% were not being
treated. A total of 41 students (14 men and 27 women)
who did not have a past history of asthma and did not
recognize themselves as having asthma had asthmatic
symptoms within the last year. They accounted for 7.0%
of the 584 students. Even if the students did not have a
past history of asthma, they were also considered to have
asthma when they had any asthmatic symptoms within
the last year and their FENO was ≥ 38.0 ppb. FENO was ≥
38.0 ppb in 11 (26.8%; 7 men and 4 women) of 41 stu-
dents. A significantly greater percentage of men (50.0%)
than women (14.8%) had a FENO ≥ 38.0 ppb (p < 0.05)
(Figure 5C).
5. Nasal allergies including hay fever
Of the 584 students, 314 (53.8%) answered “Yes” to the
question “Do you have any nasal allergies including hay
fever?” FENO was significantly higher in students who
had any nasal allergies including hay fever than in other
students (41.4 ± 32.2 ppb vs. 31.3 ± 25.4 ppb, mean ±
SD, p < 0.01). The percentage of students who had any
nasal allergies did not differ between men (54.9%, 146 of
266) and women (52.8%, 168 of 318).
Discussion
T h eg o l ds t a n d a r do fa s t h m ad i a g n o s i si so b s t r u c t i v e
lung disease with airway reversibility, or airway reactivity
Figure 2 Ag e n d e rd i f f e r e n c ei nF ENO and the percentage of students whose FENO was ≥ 38.0 ppb. In the 584 students ranging in age from 18
to 24 years, FENO was significantly higher in men than in women (**, p < 0.01) (A). Overall, 32.7% of the 584 students, including 41.2% of male
students and 25.2% of female students, had FENO ≥ 38.0 ppb. The percentage of men was significantly higher than that of women (p < 0.01) (B).
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Page 4 of 8confirmed by challenge testing, not history or symp-
toms. Information obtained from the questionnaire
which only asks asthmatic symptoms and history of
asthma is not enough to make diagnosis of asthma,
because clinical suspicion of asthma should be con-
firmed by objective measures of pulmonary function
[20]. Strictly, current asthma symptoms on the ECRHS
questionnaire are not equal to clinically current symp-
toms because this questionnaire is designed to detect
asthma symptoms over 1 year. Although we must also
emphasize that the ROC curve was constructed only to
classify subjects of this study and that it was not con-
structed to help diagnose asthma, a previous study using
the same offline method proposed that the optimal cut-
off value of FENO was 38.0 ppb for detecting allergic
airway inflammation in an adult population [10]. This
cut-off value was equal to that we used in this study.
In our survey, two symptoms, wheeze and a nocturnal
attack of cough were most frequently reported. FENO
was ≥ 38.0 ppb in more than 75% of subjects who had
wheeze. In those students who had experienced wheez-
ing, the percentage whose FENO was ≥ 38.0 ppb was
significantly higher in men than in women. This sug-
gests that wheeze as a subjective symptom correlates
with the presence of chronic eosinophilic airway inflam-
mation especially in men. In fact, wheeze is the most
Figure 3 The percentage of students with wheezes or coughs
whose FENO was ≥ 38.0 ppb. The percentage of students whose
FENO was ≥ 38.0 ppb was higher in students with wheezes than in
those with nocturnal attacks of cough (A). Among students with
wheezes, FENO was ≥ 38.0 ppb in a significantly higher percentage
of male than female students (p < 0.05) (B). Nocturnal attacks of
cough were observed significantly more often in women than in
men (p < 0.05). Among students with nocturnal attacks of cough,
FENO was ≥ 38.0 ppb in a smaller percentage of female than male
students (C).
Figure 4 The prevalence of asthma symptoms in students
ranging in age from 18 to 24 years. Overall, 77 (13.2%) of 584
students experienced any asthmatic symptoms within the last year.
One-year prevalence of asthma symptoms in university students
ranging in age from 18 to 24 years was expected to be 13.2% at a
maximum (A). FENO was over 38.0 ppb in 42 of the 77 students.
The prevalence of asthma symptoms was estimated to be 7.2% by
considering FENO levels (B).
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Page 5 of 8sensitive and specific symptom for the diagnosis of
asthma [21]. Although a few studies have described gen-
der differences in asthmatic symptoms [22-24], a noc-
turnal cough attack was observed significantly more
o f t e ni nw o m e nt h a ni nm e ni no u rs u r v e ya sw e l la sa
previous study in Australia [22]. Less than 30% of sub-
jects who had a nocturnal attack of cough had an FENO
≥ 38.0 ppb. It was even smaller when subjects were lim-
ited to women. This suggests that a nocturnal cough
attack as a subjective symptom is not closely related to
the presence of chronic eosinophilic airway inflamma-
tion that is characteristic for typical asthma. Although a
cough attack disturbing sleep is also one of the impor-
tant symptoms that indicates asthma [22,25], it might be
risky to make diagnosis of asthma based on this symp-
tom especially in women.
In our study, FENO was significantly higher in men
than in women aged between 18 to 24 years. Similarly, it
has been reported that FENO was significantly higher in
males than in females, in healthy children and healthy
adults [26-29]. However, there are also some reports that
deny the gender difference of FENO [30-35]. Thus, the
influence of gender on FENO is still a matter of some
controversy. Because gender difference in FENO was
observed in our study, we tried to construct the ROC
curve separately for males and females. When 44.0 ppb
was used as the cut-off value for men and 37.0 ppb was
for women, both sensitivity and specificity were much
the same between men and women. We reanalyzed all
data by using the gender-specific cut-off value to make
a s s u r a n c ed o u b l ys u r e .A sar e s u l t ,o n l yo n em a nw a s
excluded from asthma and only one woman was included
in asthma. Namely, the man who had experienced a
cough attack was not considered to have asthma because
his FENO was 38.4 ppb and the woman who had experi-
enced wheezing was considered to have asthma because
her FENO was 37.5 ppb. When we used the gender-speci-
fic cut-off value, FENO levels were the cut-off value and
over in 34.8% of 266 male students and 26.1% of 318
female students. The percentage was significantly greater
i nm e nt h a ni nw o m e n( p < 0.05). Therefore, the results
in our study did not change so much even if we used the
gender-specific cut-off value.
In general, boys have a higher current prevalence of
asthma than girls. This trend is reversed in adulthood,
such that males have a lower prevalence than females.
Actually, the percentage of students with a past history of
asthma was higher in male students than in female stu-
dents in our study. Gender differences in both FENO
levels and a past history of asthma might mean that eosi-
nophilic airway inflammation induced by prolongation of
childhood asthma is currently present more in men than
in women aged 18 to 24 years. Of students in this age
group who had suffered from and still had asthma, only 3
Figure 5 The relationship between past history of asthma and
current symptoms of asthma. Overall, 17.6% of students ranging
in age from 18 to 24 years had suffered from asthma. The
percentage of students who had a past history of asthma was
significantly greater in men (21.8%) than in women (14.2%) (p <
0.05) (A). Of the students who had suffered from asthma, 35% had
current asthma symptoms. Further, 41 (7.0%) of 584 students
ranging in age from 18 to 24 years had any asthmatic symptoms,
including wheezing, a nocturnal feeling of tightness in the chest, a
nocturnal attack of shortness of breath, or a nocturnal attack of
cough, within the last year, although they did not have a past
history of asthma (B). FENO was ≥ 38.0 ppb in 11 of 41 students
who had any asthmatic symptoms within the last year, but did not
have a past history of asthma. FENO was ≥ 38.0 ppb in 7 of 14 male
students and 4 of 27 female students. The percentage of these 41
students whose FENO was ≥ 38.0 ppb was significantly greater in
men than in women (p < 0.05) (C).
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Page 6 of 8students were treated well, and 36 students still had
asthma symptoms within the last year, which suggests
that this is a problem for patients in this age group.
Furthermore, about two thirds of 36 students did not see
a doctor at the time of our survey. We assume that at
least 11 students who did not recognize themselves as
having asthma probably did have asthma because their
FENO levels were over 38.0 ppb and they had asthmatic
symptoms within the last year. These students should be
also recommended to see a doctor.
There are many other factors that can influence FENO
levels [9]. In our study, many students had nasal allergy
a n di tm a ya f f e c tF ENO levels [36,37]. As expected,
FENO was significantly higher in students who had any
nasal allergies including hay fever than in other stu-
dents. Interestingly, gender difference was not observed
in the prevalence of nasal allergy on the basis of the
questionnaire. Although Asian race may be a factor
which increases FENO levels [38], most subjects were
Japanese in this study.
The prevalence of asthma based on subjective asth-
matic symptoms was 13.2% in university students ranging
in age from 18 to 24 years when we estimated the maxi-
mum potential prevalence. The prevalence in female stu-
dents exceeded that in male students by 1.4 percentage
points. When the prevalence of asthma for the last year
was estimated on the basis of FENO levels, as well as sub-
jective asthmatic symptoms, it was 7.2%. Interestingly,
the prevalence of asthma symptoms estimated by consid-
ering FENO in men exceeded that in women by 4.1 per-
centage points. This indicates that prevalence of asthma
may be estimated more objectively by considering both
asthma symptoms and the degree of eosinophilic airway
inflammation. Patients with asthma in this age group
need to be adequately diagnosed and treated well.
Conclusions
The prevalence of asthma symptoms in university stu-
dents in Japan in a single year was 7.2%, estimated on the
basis of FENO levels as well as subjective asthmatic symp-
toms. The prevalence, based on both of these factors, was
higher in men than in women. Gender differences were
observed in both FENO levels and asthma symptoms.
Additional material
Additional file 1: The ROC curve constructed using FENO data in
university students. The ROC curve was constructed using FENO data
obtained from 504 students in this study (including the samples
obtained from students who were ≥ 25 years old). The asthmatic
subjects included 38 students who answered that they suffered from
asthma and had wheezing in the last year. The control subjects included
466 students who answered that they did not suffer from asthma and
did not have any asthmatic symptoms, including wheezing, a nocturnal
feeling of tightness in the chest, a nocturnal attack of shortness of
breath, or a nocturnal attack of cough in the last year, and had not
experienced chronic bronchitis-like symptoms, coughing and phlegm on
most days for a minimum of 3 months a year and for at least 2
successive years.
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